Scleroderma Renal Crisis: A Case Study

This publication has 12 references indexed in Scilit:

• Analysis of Anti-RNA Polymerase III Antibody-positive Systemic Sclerosis and Altered GPATCH2L and CTNND2 Expression in Scleroderma Renal Crisis
  The Journal of Rheumatology, 2020
• Generation of a Core Set of Items to Develop Classification Criteria for Scleroderma Renal Crisis Using Consensus Methodology
  Arthritis & Rheumatology, 2019
• Towards developing criteria for scleroderma renal crisis: A scoping review
  Autoimmunity Reviews, 2017
• Exposure to ACE inhibitors prior to the onset of scleroderma renal crisis—Results from the International Scleroderma Renal Crisis Survey
  Seminars in Arthritis and Rheumatism, 2014
• Revisiting ANCA-associated vasculitis in systemic sclerosis: clinical, serological and immunogenetic factors
  Rheumatology, 2013
• Scleroderma renal crisis: a retrospective multicentre study on 91 patients and 427 controls
  Rheumatology, 2011
• Corticosteroids and the risk of scleroderma renal crisis: a systematic review
  Rheumatology International, 2010
• Scleroderma renal crisis: patient characteristics and long-term outcomes
  QJM: An International Journal of Medicine, 2007
• Drug-induced tubulo-interstitial nephritis secondary to proton pump inhibitors: experience from a single UK renal unit
  Nephrology Dialysis Transplantation, 2004
• Failure of losartan to control blood pressure in scleroderma renal crisis
  The Lancet, 1997